Form 8-K - Current report:
SEC Accession No. 0000950170-21-000723
Filing Date
2021-08-03
Accepted
2021-08-03 17:11:17
Documents
14
Period of Report
2021-08-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alec-20210803.htm   iXBRL 8-K 46706
2 EX-99.1 alec-20210803ex99_1.htm EX-99.1 134569
3 GRAPHIC img90392132_0.jpg GRAPHIC 57391
  Complete submission text file 0000950170-21-000723.txt   387569

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alec-20210803_lab.xml EX-101.LAB 13496
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alec-20210803.xsd EX-101.SCH 2426
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alec-20210803_pre.xml EX-101.PRE 9977
7 EXTRACTED XBRL INSTANCE DOCUMENT alec-20210803_htm.xml XML 4690
Mailing Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

EIN.: 462702363 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38792 | Film No.: 211140935
SIC: 2836 Biological Products, (No Diagnostic Substances)